AFRM vs FDMT · P/E 590, rev $3.22B vs rev $37.0K
Affirm Holdings Inc (AFRM) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the AFRM and FDMT stock pages for the full models.
Not investment advice.